People · Operator
Named in public records as an officer, director or promoter · active 2008–2026 · Other Technology, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Instructure Inc | — | Other Technology | Series B | $117.1M | $375.4M | 2012 |
| CIONIC, Inc. | — | Other Technology | Series A | $35.2M | $89.8M | 2020 |
| Focus IP, Inc. | — | Other Technology | Series A | $35.0M | $4.9M | 2020 |
| Moki Mobility, Inc. | — | Other Technology | Series A | $20.1M | $26.8M | 2013 |
| SpinGo Solutions, Inc. | — | Other Technology | Seed | $12.6M | $31.5M | 2014 |
| TriCipher, Inc. | — | Other Technology | Series A | $9.0M | $83.2M | 2008 |
| Zettaset, Inc. | — | Other Technology | Series A | $7.8M | $131.8M | 2012 |
| Alliance Health Networks Inc | — | Other Health Care | Seed | $3.2M | $79.7M | 2009 |
| OpenContext Inc. | — | Other Technology | Seed | $2.0M | $13.0M | 2023 |
| Gravit, Inc. | — | Other Technology | Seed | $1.2M | $42.4M | 2019 |
NICK EFSTRATIS at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside NICK EFSTRATIS on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| John Kim | 1 | 23 |
| Byron Deeter | 1 | 17 |
| Spencer Tall | 1 | 12 |
| Eric Johnson | 1 | 11 |
| James Pavlik | 1 | 9 |
| Adam Marcus | 1 | 9 |
| FIRAS RAOUF | 1 | 7 |
| BLAKE MODERSITZKI | 1 | 6 |
| George Mulhern | 1 | 5 |
| Daniel Goldsmith | 1 | 5 |
| John Malloy | 1 | 5 |
| Morgan Rodd | 1 | 4 |
| Bill Conroy | 1 | 4 |
| HOWARD SMITH | 1 | 4 |
| Mark R. Anderson | 1 | 4 |
| Lloyd G. Waterhouse | 1 | 3 |
| John DeSantis | 1 | 3 |
| Whitney Casey | 1 | 3 |
| Jay Haladay | 1 | 3 |
| Faisal Shah | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.